Press release
PCR and NGS-Based Molecular Diagnostics Market to Reach US$ 14.36 Billion by 2034 at 10.49% CAGR
PCR and NGS-Based Molecular Diagnostics Market
Download Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00014426?utm_source=OpenPR&utm_medium=10379
According to The Insight Partners, the PCR and NGS-Based Molecular Diagnostics Market size is expected to reach US$ 14.36 Billion by 2034 from US$ 5.85 Billion in 2025. The market is estimated to record a CAGR of 10.49% from 2026 to 2034.
The growing adoption of advanced molecular testing technologies in oncology, infectious disease diagnostics, and genetic screening is significantly driving market expansion worldwide. Increasing investments in healthcare infrastructure and genomic research are also supporting long-term market growth.
Market Overview
PCR and NGS-based molecular diagnostics are advanced laboratory techniques used for detecting genetic material, identifying mutations, and analyzing pathogens with high sensitivity and specificity. PCR technology amplifies DNA and RNA sequences for accurate disease diagnosis, while NGS enables large-scale genomic sequencing and comprehensive molecular profiling.
These technologies are increasingly being integrated into clinical laboratories, hospitals, and research institutes due to their ability to deliver rapid and reliable diagnostic results. Rising awareness regarding early disease detection and personalized medicine is further accelerating market demand.
Explore Full Report @ https://www.theinsightpartners.com/reports/pcr-and-ngs-based-molecular-diagnostics-market
Key Market Drivers
Rising Prevalence of Infectious Diseases
One of the major drivers of the PCR and NGS-based molecular diagnostics market is the increasing burden of infectious diseases worldwide. Molecular diagnostic technologies provide rapid and highly accurate pathogen detection, enabling timely treatment decisions and disease management.
Growing Demand for Precision Medicine
The increasing focus on precision medicine is another critical factor driving market growth. Healthcare providers are increasingly utilizing molecular diagnostics to identify genetic mutations and develop personalized treatment strategies for patients.
NGS-based testing plays a vital role in oncology by enabling comprehensive tumor profiling and biomarker analysis. Personalized therapies based on molecular data are improving patient outcomes and supporting the growing adoption of advanced diagnostic technologies.
Technological Advancements in Molecular Testing
Continuous advancements in PCR and NGS technologies are significantly improving testing speed, accuracy, and efficiency. Manufacturers are introducing automated platforms, portable testing systems, and high-throughput sequencing solutions to enhance laboratory productivity.
The integration of artificial intelligence, bioinformatics tools, and cloud-based data analysis platforms is further transforming molecular diagnostics by simplifying genomic interpretation and improving clinical decision-making. These innovations are expected to create substantial growth opportunities for the market.
Increasing Investments in Genomic Research
Governments, healthcare organizations, and private companies are investing heavily in genomic research and molecular diagnostics infrastructure. Research initiatives focused on cancer genomics, rare diseases, and infectious disease surveillance are fueling the demand for advanced PCR and NGS technologies. Academic institutions and biotechnology companies are increasingly collaborating to accelerate genomic discoveries and expand the clinical applications of molecular diagnostics. This growing research ecosystem is expected to contribute significantly to market growth through 2034.
Emerging Market Trends
Expansion of Oncology Diagnostics
Oncology remains one of the fastest-growing application areas for PCR and NGS-based molecular diagnostics. The increasing incidence of cancer worldwide is driving the adoption of genomic testing for early cancer detection, tumor profiling, and treatment monitoring.
NGS technologies enable clinicians to identify multiple genetic alterations simultaneously, supporting targeted therapy selection and personalized oncology care. The growing emphasis on precision oncology is expected to remain a major market trend during the forecast period.
Adoption of Automated Diagnostic Platforms
Laboratories are increasingly adopting automated molecular diagnostic systems to improve workflow efficiency and reduce turnaround times. Automated PCR and NGS platforms minimize manual intervention, improve testing consistency, and support high-volume sample processing.
Automation is particularly important in clinical settings where rapid and accurate diagnostics are essential for patient care. This trend is expected to accelerate the deployment of advanced molecular testing technologies across healthcare facilities worldwide.
Get Full Report @ https://www.theinsightpartners.com/buy/TIPRE00014426?utm_source=OpenPR&utm_medium=10379
Growing Use of Companion Diagnostics
Companion diagnostics are gaining significant importance in targeted therapy development and personalized medicine. PCR and NGS technologies are increasingly being used to identify biomarkers that help determine the most effective treatments for individual patients. The rising number of targeted therapies approved for cancer and rare diseases is expected to boost the demand for companion diagnostic testing solutions globally.
Regional Insights
North America dominates the PCR and NGS-based molecular diagnostics market due to advanced healthcare infrastructure, strong genomic research activities, and the presence of leading biotechnology companies. Europe also represents a significant market share owing to increasing investments in precision medicine and molecular testing.
Meanwhile, the Asia Pacific region is expected to witness the fastest growth during the forecast period due to expanding healthcare infrastructure, increasing awareness regarding genetic testing, and rising investments in biotechnology research.
Key Players in the Market
According to The Insight Partners report, several major companies are actively contributing to market growth through product innovation, partnerships, and strategic expansions.
Key players include:
• F. Hoffmann-La Roche Ltd
• Thermo Fisher Scientific Inc.
• Illumina Inc.
• QIAGEN N.V.
• Agilent Technologies Inc.
• Bio-Rad Laboratories Inc.
• Danaher Corporation
• Abbott Laboratories
• BGI Genomics
• Sysmex Corporation
Related Reports @
PCR Molecular Diagnostics Market - https://www.theinsightpartners.com/reports/pcr-molecular-diagnostics-market
Contact Us:
Contact Person: Ankit Mathur
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876
About Us -
The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release PCR and NGS-Based Molecular Diagnostics Market to Reach US$ 14.36 Billion by 2034 at 10.49% CAGR here
News-ID: 4528622 • Views: …
More Releases from The Insight Partners
Armor Materials Market Demand, Share & Growth by 2034
Armor materials are specialized substances designed to protect individuals and assets from various forms of threats, including ballistic impacts, blasts, and other hazardous conditions. These materials are utilized in a wide range of applications, including personal protective equipment, military vehicles, aerospace components, and civil infrastructure. The demand for advanced armor solutions is driven by the need for enhanced safety and security in both military and civilian contexts.
To Get Sample Copy…
Plant based Foods Market Size is Expected to Reach US$ 112.98 Billion by 2034 fr …
The Plant based Foods Market is poised for remarkable growth, driven by increasing consumer awareness regarding health, sustainability, and ethical food choices. According to the latest market research by The Insight Partners, the Plant based Foods Market is projected to grow from US$ 50.40 Billion in 2025 to US$ 112.98 Billion by 2034, registering a CAGR of 9.38% during the forecast period from 2026 to 2034. The rising popularity of…
Multivitamin Tablets and Capsules Market to Reach US$ 49.37 Billion by 2034 at a …
The multivitamin tablets and capsules market is witnessing consistent growth, driven by rising consumer awareness regarding preventive healthcare, increasing demand for dietary supplements, and expanding health and wellness trends across developed and emerging economies. According to The Insight Partners, the global multivitamin tablets and capsules market size is projected to grow from US$ 34.99 billion in 2025 to US$ 49.37 billion by 2034, registering a CAGR of 3.90% during the…
Global Green (Vegetative) Roofing Market Worth US$ 12.46 Billion by 2034, Growin …
The global Green (Vegetative) Roofing Market is poised for remarkable growth as sustainability initiatives, urban greening programs, and energy-efficient construction practices continue to gain momentum worldwide. According to the latest market analysis by The Insight Partners, the market is expected to grow from US$ 3.14 billion in 2025 to US$ 12.46 billion by 2034, registering a robust CAGR of 16.54% during the forecast period of 2026-2034.
Get Sample Copy of Report…
More Releases for NGS
Next Generation Sequencing (NGS) : - Key Industry Dynamics
The Next Generation Sequencing (NGS) market size is projected to reach US$ 34.75 billion by 2031 from US$ 10.00 billion in 2023. The market is expected to register a CAGR of 16.8% during 2023-2031. Increased throughput and reduced costs is likely to remain key trends in the market.
Next-generation sequencing (NGS) carries a shift in genomics research, offering unmatched capabilities for analyzing DNA and RNA molecules in a high-throughput and cost-effective…
Next-Generation Sequencing (NGS) Services Next-Generation Sequencing (NGS) Servi …
Global Next-Generation Sequencing (NGS) Services Market Report encompasses market data, such as trends, consumer behavior, and competitive analysis in a way that allows businesses to identify opportunities in the market. The objective of the market research is understood very clearly by DBMR team before the creation of report commences. Intense research takes place to accurately analyze market dynamics and consumer behaviour included in the report.
Global Next-Generation Sequencing (NGS) Services Market,…
Complete PDF Guide to NGS Sample Preparation
The NGS sample preparations determine components in the samples, such as blood, urine, and others, in animals.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 @ https://www.theinsightpartners.com/sample/TIPRE00006573?utm_source=OpenPR&utm_medium=10379
The type of analyzers includes urine analyzers, blood gas & electrolyte analyzers, glucometers, and others used by medical labs, hospitals, and people at home.
Top Companies Analysis -
Agilent Technologies, Inc.
Becton, Dickinson and Company
Beckman Coulter
F. Hoffmann-La Roche AG
Illumina, Inc.
…
NGS Sample Preparation Market - Preparing for Precision: NGS Sample Preparation …
Newark, New Castle, USA: The "NGS Sample Preparation Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
NGS Sample Preparation Market: https://www.growthplusreports.com/report/ngs-sample-preparation-market/8504
This latest report researches the industry structure,…
NGS Library Preparation Market - Sequencing Solutions, Redefined: Innovations in …
Newark, New Castle, USA - new report, titled NGS Library Preparation Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the NGS Library Preparation market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global NGS Library Preparation market. The report offers an overview of…
Next Generation Sequencing (NGS) Data Analysis Market Research Report 2020Next G …
The Next Generation Sequencing (NGS) Data Analysis Market report helps identify the biggest opportunities in Next Generation Sequencing (NGS) Data Analysis industry space and offers accurate latent demand forecasting that empowers quantitative decision making among Next Generation Sequencing (NGS) Data Analysis market players and new entrants. Investors will gain a clear insight on the dominant players in Next Generation Sequencing (NGS) Data Analysis industry and their future forecasts. Furthermore, readers…
